Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Depomed to refinance $375M of high-cost debt; expects Q2 sales of ~$100M

Published 07/13/2017, 09:03 AM
© Reuters.  Depomed to refinance $375M of high-cost debt; expects Q2 sales of ~$100M
ASRT
-
  • Depomed (NASDAQ:DEPO) announces that it intends to refinance its existing $375M of Senior Notes that currently pay a coupon of 9.75% over three-month LIBOR (currently 1.30%).
  • Concurrently, it expects Q3 sales to be $98M - 103M and non-GAAP EBITDA of $23M - 28M. Complete results will be released in early August.
  • CEO Art Higgins says, “Our second quarter performance marked an improvement over our first quarter and was consistent with our expectations. We believe that in light of the quarter’s performance we are on track to achieve our previously stated financial guidance for the full year. Refinancing our debt is an important 2017 goal and we expect that we will be able to refinance on significantly more favorable terms given our solid net sales and EBITDA. Our intent is to close the refinancing during the quarter.”
  • Now read: Depomed business development chief to retire at end of month with golden parachute


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.